Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2025-01-13 17:45:31
Reference is made to the stock exchange release from earlier today, 13th January 2025, regarding new funding, including a convertible loan facility of NOK 15 million.
The following primary insiders, or closely related companies to primary insiders, are a part of the total investor consortium:
- Ronja Capital Investment AS, a company closely related to Board Member Tore Tønseth, NOK 3,0 million
- Vartdal Holding AS, a company closely related to Board Member Jan Endre Vartdal, NOK 1,0 million
- Brødrene Vartdal AS, a company closely related to Board Member Jan Endre Vartdal, NOK 1,0 million
- Ajea Invest AS, a company closely related to Board Member Asbjørn Solevågseide, NOK 0,5 million
- Eros AS, a company closely related to Board Member Per Magne Eggesbø, NOK 0,6 million
- Siglar AS, a company closely related to Chairman of the Board Harald Nordal, NOK 0,15 million
- Clu Invest AS, a company closely related to CEO Christer L. Valderhaug, NOK 0,1 million
- Runhild Gammelsæter, Medical Director, NOK 0,05 million
This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.